Development of neo-self antibody research for recurrent pregnancy loss and obstetric complications
Phase 1
Recruiting
- Conditions
- Recurrent pregnancy loss, obstetric complications, sterility
- Registration Number
- JPRN-UMIN000037771
- Lead Sponsor
- Kobe University Graduate School of Medicine Department of Obstetrics & Gynecology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Less than 18 years, or more than 45 years old 2) Inappropriate subjects 3) Multiple pregnancy or pregnancy with fetal anomaly
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A caste-control study evaluate whether beta2GPI/HLA-DR7 antibody is associated with recurrent pregnancy loss, obstetric complications, or sterility
- Secondary Outcome Measures
Name Time Method A cohort study for pregnant women (<21GW) evaluate whether beta2GPI/HLA-DR7 antibody is associated with obstetric complications